A report from Consumer Reports Best Buy Drugs, a public information project of Consumers Union, recommends that physicians go back to using older type drugs to fight type 2 diabetes, instead of the new and more expensive ones.
They cite not only the economic savings, but they also say that the newer drugs are not more effective. As a matter of fact one of the newer drugs, Avandia has been linked to higher risk of heart attacks. Although the risk of heart attack is not yet clearly defined, Avandia does pose a higher risk of heart failure than other diabetes drugs.
The study shows that the older drugs work just as well in most people, therefor there is no reason to prescribe the newer, more expensive ones. It will save money for patients who cannot afford the higher cost as well as insurance companies and hospitals. Add to that the fact that the report shows doctors recommending more than one drug and it brings the monetary factor even more into play.
When it came to comparing prices, the researchers choose three generic drugs to compare with the new ones and this is the result. The generic drugs cost $10 to $60 a month. Avandia costs $131 to $262 a month, depending on dose. Actos costs from $142 to $221, depending on dose, and Januvia, costs around $200 a month. This is not a small change difference. Just think of the savings in only one year’s time. Of course, health comes first, but why pay hundreds of dollars a month for a drug that does the same as one that costs less than $100.
Diabetes is so serious a problem that some experts are saying we are on the verge of an epidemic. To back up that fact, they state that in 1980 2.5% of the population had diabetes, now the percentage is 7% and the numbers are increasing every day. It affects all age groups. There is some evidence that lifestyle changes can help, but we need to develop those habits before we need these drugs, not after. This is especially true in the younger generation, where studies show that the rise in cases of diabetes is running parallel to the rates of obesity. A change in lifestyle will help these young people have a healthy life not only now, but for the rest of their life as well.
This report is based on research done at Johns Hopkins University covering scientific evidence on oral diabetes drugs. They based their research on the findings in more than 216 articles on diabetes drugs. The sponsor of the study was The Federal Agency for Healthcare Research and Quality
Source: Consure Reports Best Buy Drugs http://www.crbestbuydrugs.org/